Consistent with a previous report in uterine sarcomas27, nearly half of BRCA2 (41%) and RAD51B (47%) alterations occurred in sarcomas of uterine origin, with RAD51B or BRCA2 each mutated in 7% of ULMS cases. This evidence concerns the gene RAD51B and sarcoma.